OCRA recently joined the Inter-Organization Cancer Genetics Clinical Evidence Coalition (INTERACT), which is working to ensure genetic testing access for all who may carry inherited mutations that increase the risk of ovarian and other cancers.
The coalition, which includes patient advocacy and industry members, endeavors to drive changes in cancer-related genetic testing policies to expand access. Learn more about INTERACT and the collective goals of its members via this announcement from the coalition.
OCRA continues to champion genetic testing as an important tool in the fight against ovarian and gynecologic cancers, with initiatives that include offering free genetic test kits for those who qualify.
